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Background
The quest to create an HIV-1 vaccine capable of eliciting
broadly neutralizing antibodies (bnAbs) against Env has
been challenging. Amongst others, one difficulty in creat-
ing a potent immunogen resides in the substantial overall
sequence variability of HIV Env across different clades.
One of the few conserved regions of Env is the membrane
proximal external region (MPER) of gp41, a tryptophan-
rich stretch spanning residues 660 to 683. To date, three
bnAbs have had their primary epitope mapped to this
region: 2F5, Z13 and 4E10.
Methods
In this study, we first extensively describe the variability of
the gp41 MPER by performing a search of the Los Alamos
National Laboratory HIV database and show variation at
each position of the MPER. Subsequently, we evaluate the
ability of the bnAb 2F5 to recognize varying sequences of
the gp41 MPER at a molecular level. We report our
attempts to co-crystallize 2F5 Fab' fragments with 28 dif-
ferent MPER peptides. In 16 cases, the resulting crystal
structures show the various MPER peptides bound to the
2F5 Fab'.
Results
A variety of amino acid substitutions outside the
664DKW666 core epitope are tolerated. However, changes
at the 664DKW666 motif itself are restricted to those resi-
dues that preserve the aspartate negative charge, the stack-
ing arrangement between the beta-turn tryptophan and
lysine, and the positive charge of the latter. We also char-
acterize a possible molecular mechanism of 2F5 escape by
sequence variability at position 667, when an alanine res-
idue is replaced by amino acids with bulkier side chains,
a substitution often found in HIV-1 clade C isolates.
Conclusion
From our results, we propose an expanded molecular
model of epitope recognition by bnAb 2F5, which will
help in guiding future attempts at designing small mole-
cule MPER-like vaccines capable of eliciting 2F5-like
bnAbs.
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